Currently, only 30 percent of insurers will cover these medications, another way weight stigma and the misconception that obesity is purely a lifestyle issue continues to harm people
A daily tablet that delivers around 12% average weight loss with proper medical support is a far better outcome than a high-dose injection that never gets used
Although marketed as safer alternatives, obesity medications are not free from adverse effects
Since 2015, SHL has supported the launch of six combination products indicated for cardiometabolic diseases, including incretin mimetics for T2D and obesity in particular, as well as PCSK9 inhibitors for hyperlipidaemia
For instance, Mounjaros label recommends that people taking birth control pills switch to a non-oral contraceptive method, or add a barrier method of contraception for four weeks after initiation and four weeks after each dose escalation. While GLP-1 drug labels do not contain specific recommendations about birth control, you may still want to consider extra protection for peace of mind